RSV bivalent prefusion F protein-based vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RSV bivalent prefusion F protein-based vaccine, covering 2025-11-25 to 2025-11-25. Get the full timeline:
Most recent: Clinical Trial Update: Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults [Phase 4]